Company Overview of Alpha-Beta Technology
As of 2001, Alpha-Beta Technology went out of business. In January 1999, Alpha-Beta Technology, Inc. entered into an Assignment for the Benefit of Creditors to liquidate its assets. As of September 30, 1998, Alpha-Beta Technology, Inc., a development stage company, was developing immune modulation pharmaceutical products composed of complex carbohydrates and was discovering and developing anti-fungal diagnostics and drugs. The company's lead product, Betafectin® PGG-glucan, was a proprietary carbohydrate polymer. In January 1998, Betafectin® was being tested for the prevention of serious infections in upper gastrointestinal surgery patients. In addition, Alpha-Beta had developed a rapid in v...
One Innovation Drive
Worcester, MA 01605
Key Executives for Alpha-Beta Technology
Chief Financial Officer and Vice President of Finance
Chief Operating Officer, Executive Vice President, Treasurer, Director and Clerk
Vice President of Operations
Vice President of Antifungal Research and General Manager of Denver Operations
Vice President of Discovery Research
Compensation as of Fiscal Year 2014.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries